Dose-response effect of the lercanidipine/enalapril combination: a pooled analysis

被引:1
作者
Rizzoni, Damiano [1 ]
机构
[1] Univ Brescia, Dept Clin & Expt Sci, Internal Med, I-25123 Brescia, Italy
关键词
Combination treatment; Dose-response; Enalapril; Hypertension; Lercanidipine; SAFETY; HYPERTENSION; EFFICACY; ENALAPRIL; OFFICE; DRUGS;
D O I
10.1080/03007995.2016.1218836
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The dose-effect relationship of fixed-dose combinations of anti-hypertensive drugs has been only poorly explored. This pooled analysis investigates the dose-response relationship of fixed-dose lercanidipine+enalapril in patients with mild-to-moderate hypertension. Research design and methods: This was an individual patient data analysis of four randomized studies (n = 2340). Main outcome measures: The primary efficacy variable was the change from baseline in sitting diastolic blood pressure (SDBP). Secondary variables were change from baseline in sitting systolic BP (SSBP), proportion of responder patients, and safety. Results: All fixed-dose combinations were superior to placebo in the reduction of SDBP. The greatest effect was observed with the market-available combination lercanidipine 20 mg/enalapril 20 mg (-15.3 mmHg vs. baseline; p < 0.05). The reduction in SDBP associated with the other two marketed fixed combinations of lercanidipine/enalapril were -10.7 mmHg for the 10 mg/20 mg combination and -9.8 mmHg for the 10 mg/10 mg combination (p < .05 for both comparisons). Similar findings were reported for SSBP reduction: the greatest effect was observed with lercanidipine 20 mg/enalapril 20 mg (-19.2mmHg). The reduction in SSBP was-12.5mmHg for the 10 mg/20 mg combination and -11.1 mmHg for the 10 mg/10 mg combination (p < .05 for all comparisons). The highest responder rate was reported with lercanidipine 20 mg/enalapril 20 mg (75.0%); this figure was 56.1% with the 10 mg/20 mg and 53.0% with the 10/10 mg combination. No safety concerns were reported. Conclusion: This pooled analysis of four randomized studies shows evidence of a dose-response effect in BP reduction with different fixed combinations of lercanidipine_enalapril. To our knowledge, this is the first analysis investigating the dose-response effect of a specific fixed-dose combination of antihypertensive agents. Further studies on this intriguing topic are however necessary.
引用
收藏
页码:17 / 23
页数:7
相关论文
共 50 条
  • [21] RETRACTED: Enalapril/lercanidipine combination on markers of cardiovascular risk: a randomized study (Retracted article. See vol. 9, pg. 822, 2015)
    Derosa, Giuseppe
    Bonaventura, Aldo
    Romano, Davide
    Bianchi, Lucio
    Fogari, Elena
    D'Angelo, Angela
    Maffioli, Pamela
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2014, 8 (06) : 422 - 428
  • [22] Acute dose-response, double-blind, placebo-controlled pilot study of lercanidipine in patients with angina pectoris
    Acanfora, D
    Gheorghiade, M
    Rotiroti, D
    Trojano, L
    Rengo, G
    Furgi, G
    Papa, A
    Picone, C
    Nicolino, A
    Odierna, L
    Rengo, F
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2000, 61 (05): : 255 - 265
  • [23] Dose-response meta-analysis of differences in means
    Crippa, Alessio
    Orsini, Nicola
    BMC MEDICAL RESEARCH METHODOLOGY, 2016, 16
  • [24] Fixed combination of the calcium channel blocker lercanidipine and angiotensin converting enzyme inhibitor enalapril: possibility of usage
    Ostroumova, O. D.
    Kopchenov, I. I.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2013, 9 (02) : 177 - 182
  • [25] Comparison of two strategies for intensifying antihypertensive treatment - Low-dose combination (enalapril plus felodipine ER) versus increased dose of monotherapy (enalapril)
    Elliott, WJ
    Montoro, R
    Smith, D
    Leibowitz, M
    Hwang, C
    Gradman, AH
    Schleman, N
    Klibaner, M
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (07) : 691 - 696
  • [26] Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database
    Mancia, Giuseppe
    Omboni, Stefano
    Chazova, Irina
    Coca, Antonio
    Girerd, Xavier
    Haller, Hermann
    Parati, Gianfranco
    Pauletto, Paolo
    Pupek-Musialik, Danuta
    Svyshchenko, Yevgeniya
    JOURNAL OF HYPERTENSION, 2016, 34 (01) : 139 - 148
  • [27] Effects of curcumin on blood pressure: A systematic review and dose-response meta-analysis
    Karimi, Arash
    Jazani, Arezoo Moini
    Darzi, Melika
    Azgomi, Ramin Nasimi Doost
    Vajdi, Mahdi
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2023, 33 (11) : 2089 - 2101
  • [28] Lercanidipine, enalapril and their combination in the treatment of elderly hypertensive patients: placebo-controlled, randomized, crossover study with four ABPM
    J G Puig
    C Calvo
    O Luurila
    H Luurila
    S Sulosaari
    A Strandberg
    C Ghezzi
    Journal of Human Hypertension, 2007, 21 : 917 - 924
  • [29] Lercanidipine, enalapril and their combination in the treatment of elderly hypertensive patients: placebo-controlled, randomized, crossover study with four ABPM
    Puig, J. G.
    Calvo, C.
    Luurila, O.
    Luurila, H.
    Sulosaari, S.
    Strandberg, A.
    Ghezzi, C.
    JOURNAL OF HUMAN HYPERTENSION, 2007, 21 (12) : 917 - 924
  • [30] Efficacy and safety of Lercanidipine in combination with Enalapril in HBP. Preliminary results of Zanycontrol Study Group
    Guillen, VFG
    Abellan, J
    Llisterri, JL
    Sanchis, C
    Navarro, A
    Merino, J
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 115A - 115A